Guido Freckmann (Germany)
Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
Scientific Operations
Dr. Guido Freckmann, MD, is Medical Director and General Manager of the “Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm” (IfDT), Ulm, Germany. The IfDT is an independent research organization specialized to diabetes technology. Dr. Freckmann is a general practitioner and diabetologist of the German Diabetes Association. As a study physician at the IfDT, he was principle investigator for different studies, about e.g. CGM systems, development of closed loop systems or insulin pumps and further diabetes technologies and cooperates with several industrial and non-industrial partners. His expertise in blood glucose monitoring systems (BGMS) contributed to the IfDT being accredited and internationally renowned as testing laboratory for BGMS following ISO 15197. Dr. Freckmann supports publication of all study results and is author of several scientific papers about BGMS or CGMS accuracy and further topics. In addition, he is member of the managing board of the diabetes technology working group (AGDT) and the commission for laboratory diagnostics (KLD) of the German Diabetes Association. He is member of the POCT section of the German Association of Clinical Chemistry. He’s also chairman of the working group on continuous glucose monitoring of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).

Presenter of 2 Presentations

 Conference Calendar

Accuracy evaluation of patch pumps – an update

Session Name
0040 - Virtual Parallel Industry Symposium (Not Included In The Main Event CME/CPD Credit) (ID 1)
Session Type
Industry Symposium
Date
Wed, 27.04.2022
Session Time
14:30 - 16:00
Room
Virtual Hall 1.1
Presenter
Lecture Time
15:28 - 15:44

Accuracy of glucose sensors in patients with acute or chronic comorbidities

Session Name
0420 - PARALLEL SESSION - SENSORS IN HOSPITALS (ID 26)
Session Type
Parallel Session
Date
Fri, 29.04.2022
Session Time
09:00 - 10:00
Room
Hall 115
Presenter
Lecture Time
09:00 - 09:20

Abstract

Abstract Body

Continuous glucose monitors (CGMs) have become part of routine diabetes care in the last years. The use of CGM for the management of diabetes in special patient groups with comorbidities, in hospitals and nursing homes is of great interest and gets additionally stimulated by coronavirus disease that necessitates remote monitoring. However, these patient groups or settings are usually not represented in large studies on reliability and accuracy of CGM devices. Different physiological processes and possibly interfering medication might impair CGM performance. In the last years a couple of small studies that evaluated the accuracy of CGM in different patient groups and settings, like patients undergoing dialysis or ICU patients, were published. The presentation will provide a brief overview about studies and study results and will discuss the consequences of these results for CGM use in such patient groups.

Hide